CSIMarket
 


Scynexis inc   (SCYX)
Other Ticker:  
 

Scynexis Inc 's Long Term Debt to Equity

SCYX's quarterly Long Term Debt to Equity and Long Term Debt, Equity growth




SCYX Long Term Debt to Equity (Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
Y / Y Equity Change 410.34 % 301.61 % 76.49 % 55.59 % -39.12 %
Y / Y Long Term Debt Change - - - - -
Long Term Debt to Equity MRQ 0.88 - - - -
Overall Ranking # # # # #
Seq. Equity Change 24.67 % 13.91 % 138.1 % 50.92 % -1.89 %
Seq. Long Term Debt Change - - - - -



Long Term Debt to Equity second quarter 2021 Comment
Due to net new long-term borrowings of %, Long Term Debt to Equity detoriated to 0.88, a new company high.

Within Major Pharmaceutical Preparations industry in the second quarter 2021, 94 other companies have achieved lower Long Term Debt to Equity than Scynexis Inc . While total ranking remained unchanged compare to previous quarter at no. .

Explain Long Term Debt to Equity Ratio?
Learn more about SCYX
Long Term Debt to Equity Ratio SCYX on the trailing twelve month basis
Long Term Debt to Equity second quarter 2021 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 95
Healthcare Sector # 274
Overall Market # 1857


Long Term Debt to Equity Statistics
High Average Low
0.88 0.45 0.27
(Jun 30 2021)   (Sep 30 2018)




Financial Statements
Scynexis Inc 's Equity $ 32 Millions Visit SCYX's Balance sheet
Scynexis Inc 's Long Term Debt $ 28 Millions Visit SCYX's Balance sheet
Source of SCYX's Sales Visit SCYX's Sales by Geography




Companies with similar Long Term Debt to Equity in the quarter endingJun 30 2021, within Major Pharmaceutical Preparations Industry Long Term Debt to EquityJun 30 2021 MRQ Long Term DebtJun 30 2021 MRQ Equity
Puma Biotechnology Inc   2.33 $ 68.706  Millions$ 29.469  Millions
Sarepta Therapeutics Inc   2.25 $ 1,092.985  Millions$ 485.108  Millions
Eli Lilly And Company  2.21 $ 14,736.600  Millions$ 6,663.500  Millions
Ptc Therapeutics inc   2.19 $ 430.496  Millions$ 196.577  Millions
Cytokinetics Incorporated  2.16 $ 35.538  Millions$ 16.489  Millions
Teva Pharmaceutical Industries Ltd  1.91 $ 21,602.000  Millions$ 11,311.000  Millions
Amicus Therapeutics inc   1.83 $ 390.434  Millions$ 213.910  Millions
Maravai Lifesciences Holdings Inc   1.75 $ 582.209  Millions$ 333.141  Millions
Phibro Animal Health Corp  1.60 $ 382.710  Millions$ 238.529  Millions
Harmony Biosciences Holdings Inc   1.55 $ 195.610  Millions$ 126.551  Millions
Zoetis Inc   1.51 $ 6,592.000  Millions$ 4,352.000  Millions
Revance Therapeutics Inc   1.50 $ 280.003  Millions$ 186.235  Millions
Chembio Diagnostics Inc   1.22 $ 18.478  Millions$ 15.103  Millions
Avadel Pharmaceuticals Plc  1.19 $ 141.774  Millions$ 118.880  Millions
Ionis Pharmaceuticals Inc   1.16 $ 677.418  Millions$ 582.674  Millions
Bristol Myers Squibb Co  1.15 $ 42,503.000  Millions$ 36,874.000  Millions
Prestige Consumer Healthcare Inc   1.09 $ 1,545.352  Millions$ 1,416.247  Millions
Insmed Inc  1.03 $ 548.745  Millions$ 531.053  Millions
Innoviva inc   0.99 $ 389.989  Millions$ 393.745  Millions
Ani Pharmaceuticals inc  0.99 $ 189.525  Millions$ 191.917  Millions
Viatris Inc   0.99 $ 20,917.000  Millions$ 21,206.900  Millions
Heron Therapeutics Inc   0.93 $ 148.982  Millions$ 160.112  Millions
Kala Pharmaceuticals inc   0.93 $ 78.055  Millions$ 84.270  Millions
Collegium Pharmaceutical inc   0.89 $ 225.455  Millions$ 253.066  Millions
Scynexis inc   0.88 $ 28.376  Millions$ 32.320  Millions
Athenex Inc   0.86 $ 145.271  Millions$ 169.880  Millions
Evoke Pharma Inc  0.84 $ 5.000  Millions$ 5.966  Millions
Catalent Inc   0.81 $ 3,166.000  Millions$ 3,915.000  Millions
Jaguar Health inc   0.76 $ 24.195  Millions$ 31.785  Millions
Skye Bioscience Inc   0.73 $ 1.669  Millions$ 2.271  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SNPO's Profile

Stock Price

SNPO's Financials

Business Description

Fundamentals

Charts & Quotes

SNPO's News

Suppliers

SNPO's Competitors

Customers & Markets

Economic Indicators

SNPO's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071